VanEck Pharmaceutical ETF

1. 01

   Set a 52-week high on 4 Nov 2026

   Closed at $122.11 on 4 Nov 2026: 0.0% below the 52-week high of $122.13 (4 Nov 2026) and 31.1% above the low of $93.11 (7 Nov 2025).

   Daily price bars, split-adjusted · as of 4 Nov 2026

2. 02

   7.0 days to cover short interest

   2.5M shares were sold short at the 15 Oct 2026 settlement, 27.6% of the 9.2M shares outstanding; covering them would take 7.0 days of average volume. Short interest is reported twice a month, on a lag.

   Exchange short-interest filing · as of 15 Oct 2026

3. 03

   Rose 3.0% on 4 Nov 2026

   The 4 Nov 2026 gain of 3.0% was 3.2× its average daily move of 0.9% over the past year, and its largest one-day gain since 19 Aug 2026.

   Daily closes, split-adjusted · as of 4 Nov 2026

4. 04

   Ahead of SPY over 1 year

   1 month: +12.9% (SPY −1.6%). 3 months: +11.1% (SPY −0.4%). 1 year: +31.7% (SPY +13.6%). Price change to the 4 Nov 2026 close; dividends excluded.

   Daily closes, split-adjusted: PPH, SPY · as of 4 Nov 2026

5. 05

   Above its 50- and 200-day averages

   The 4 Nov 2026 close of $122.11 was 8.3% above its 50-day average ($112.77) and 12.9% above its 200-day average ($108.13). It has closed above the 200-day for 277 sessions, since 30 Sep 2025. The 50-day average crossed above the 200-day on 9 Oct 2025, 269 sessions ago.

   Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026

At the 4 Nov 2026 close